UBS AM’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
UBS AM's CLYM Position: Q3 2026 in Review
UBS AM opened a new position in Climb Bio (CLYM) in Q3 2026: 413 shares worth $4.74K. The stake represents ﹤0.01% of the portfolio and ranks #3916 among its holdings.
112 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- UBS AM held 413 shares of Climb Bio worth $4.74K as of Q3 2026.
- Climb Bio was a new UBS AM position in Q3 2026.
- Climb Bio made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3916 holding.
- 112 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.